Company: PSTV
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001193125-25-161239
Chunk: 1

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-18
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit      Description                                                                               
                                                                                                         
   Number                                                                                                
     16.1      Letter from BDO USA, P. C. to the Securities and Exchange Commission dated July 18, 2025  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data file (embedded within the Inline XBRL document)               

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 18, 2025

  PLUS THERAPEUTICS, INC.                
  By: /s/ Marc H. Hedrick, M. D.         
  Marc H. Hedrick, M. D.                 
  President and Chief Executive Officer